GLP-1 therapy helps reduce cravings and appetite, but lifestyle changeslike balanced nutrition and regular activityhelp maximize results
Single Research Group Dominance: The vast majority of published studies originate from a single research group at the University of Zagreb, Croatia, and the lack of independent replication from other laboratories is a noted limitation across the scientific community
Ipamorelin is a synthetic pentapeptide (H-Aib-His-D-2Nal-D-Phe-Lys-NH2, MW 711.86 g/mol, CAS 170851-70-4, PubChem CID 11226745) designed at Novo Nordisk by Raun, Ankersen, Johansen, and colleagues across the mid-1990s
Greater Dosing Flexibility for Personalized Care : Zepbound offers a wider range of dosing strengths and is approved for maintenance at 5 mg, 10 mg, and 15 mg
I'm sure at some point we'll feel comfortable, but there are these inertia points and these are models that are getting worked out today
SURMOUNT-5: The First Direct Head-to-Head Trial For years, comparing tirzepatide weight loss results to semaglutide weight loss results required inferring from separate trials run in different patient groups
